SF
JAZZ icon

Synovus Financial’s Jazz Pharmaceuticals JAZZ Stock Holding History

Synovus Financial’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,699
Closed -$459K – 926
2025
Q1 		$459K Sell
3,699
-15,507
-81% -$2.02M 0.01% 679
2024
Q4 		$2.37M Buy
19,206
+100
+0.5% +$11.8K 0.03% 319
2024
Q3 		$2.13M Buy
19,106
+451
+2% +$49.4K 0.02% 365
2024
Q2 		$1.99M Buy
18,655
+91
+0.5% +$10K 0.03% 341
2024
Q1 		$2.24M Buy
18,564
+239
+1% +$29.3K 0.03% 321
2023
Q4 		$2.25M Buy
18,325
+108
+0.6% +$13.5K 0.03% 302
2023
Q3 		$2.36M Buy
+18,217
New +$2.43M 0.03% 315
2020
Q3 		– Sell
-3,208
Closed -$354K – 1078
2020
Q2 		$354K Sell
3,208
-168
-5% -$18.6K 0.01% 539
2020
Q1 		$328K Buy
3,376
+451
+15% +$58.3K ﹤0.01% 646
2019
Q4 		$435K Buy
2,925
+164
+6% +$22.3K 0.01% 504
2019
Q3 		$363K Buy
2,761
+106
+4% +$14.2K 0.01% 537
2019
Q2 		$384K Buy
2,655
+2,351
+773% +$316K 0.01% 506
2019
Q1 		$44K Hold
304
– – ﹤0.01% 844
2018
Q4 		$38K Hold
304
– – ﹤0.01% 849
2018
Q3 		$51K Buy
+304
New +$52.3K ﹤0.01% 838

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Synovus Financial's JAZZ Position: Q2 2025 in Review

Synovus Financial sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2025, closing a stake of 3,699 shares — an estimated $459K sold.

Synovus Financial first reported a position in JAZZ in Q3 2018 and held it in 15 quarters. The position peaked at $2.37M in Q4 2024. 502 funds tracked by Wall St. Rank hold JAZZ as of Q2 2025.

  • Synovus Financial reported no remaining Jazz Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Synovus Financial sold 3,699 Jazz Pharmaceuticals shares in Q2 2025, an estimated $459K.
  • Synovus Financial first reported a position in Jazz Pharmaceuticals in Q3 2018 and held it in 15 quarters.
  • Synovus Financial's Jazz Pharmaceuticals position peaked at $2.37M in Q4 2024.
  • 502 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2025.

Based on Synovus Financial's 13F filing for Q2 2025, filed 14 Aug 2025.